Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transition
暂无分享,去创建一个
M. Tetzlaff | P. Nagarajan | D. Ivan | V. Prieto | P. Aung | Elizabeth Keiser | J. Curry | A. Giubellino | Shira Ronen | C. Torres-Cabala | DongHyang Kwon | C. Torres‐Cabala
[1] M. Nakashima,et al. Cutaneous pilomatrical carcinosarcoma: a case report with molecular analysis and literature review , 2020, Diagnostic Pathology.
[2] Yihua Zhang,et al. Long Non-Coding RNA Plasmacytoma Variant Translocation 1 (PVT1) Enhances Proliferation, Migration, and Epithelial-Mesenchymal Transition (EMT) of Pituitary Adenoma Cells by Activating β-Catenin, c-Myc, and Cyclin D1 Expression , 2019, Medical science monitor : international medical journal of experimental and clinical research.
[3] S. Ong,et al. Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma , 2019, Cancers.
[4] P. Hershberger,et al. Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy. , 2019, Trends in cancer.
[5] Kevin K. Chang,et al. RETRACTED ARTICLE: Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas , 2018, Oncogenesis.
[6] F. Afaq,et al. Potential therapeutic targets of epithelial-mesenchymal transition in melanoma. , 2017, Cancer letters.
[7] Feng Zhu,et al. Long Noncoding RNA PVT1 Promotes EMT and Cell Proliferation and Migration Through Downregulating p21 in Pancreatic Cancer Cells , 2017, Technology in cancer research & treatment.
[8] S. Florell,et al. Cutaneous carcinosarcoma: a series of six cases and a review of the literature , 2017, Journal of cutaneous pathology.
[9] S. Dalle,et al. [Malignant transformation of an eccrine spiradenoma]. , 2017, Annales de dermatologie et de venereologie.
[10] Hye-Min Jeon,et al. MET: roles in epithelial-mesenchymal transition and cancer stemness. , 2017, Annals of translational medicine.
[11] Haibo Hu,et al. High expression of lncRNA PVT1 promotes invasion by inducing epithelial-to-mesenchymal transition in esophageal cancer , 2016, Oncology letters.
[12] F. Gao,et al. Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway , 2015, Oncotarget.
[13] N. Palanisamy,et al. Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal losses. , 2015, Human pathology.
[14] R. Cason,et al. Cutaneous carcinosarcoma and the EMT: to transition, or not to transition? That is the question , 2015, Virchows Archiv.
[15] M. Garcia-Blanco,et al. Carcinosarcomas: tumors in transition? , 2015, Histology and histopathology.
[16] R. Darley,et al. Factors Affecting the Nuclear Localization of β‐Catenin in Normal and Malignant Tissue , 2014, Journal of cellular biochemistry.
[17] R. Cason,et al. Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing , 2014, Virchows Archiv.
[18] R. Cason,et al. Primary cutaneous carcinosarcoma: insights into its clonal origin and mutational pattern expression analysis through next-generation sequencing. , 2013, Human pathology.
[19] S. Al-Sarraj,et al. Distinct Phenotypic Differences Associated with Differential Amplification of Receptor Tyrosine Kinase Genes at 4q12 in Glioblastoma , 2013, PloS one.
[20] E. Oliva,et al. Oncogene alterations in endometrial carcinosarcomas. , 2013, Human pathology.
[21] Youngsuk Lee,et al. Primary cutaneous carcinosarcoma of the shoulder: case report with literature review. , 2013, Dermatologic Surgery.
[22] H. Meijers-Heijboer,et al. RB1 mutations and second primary malignancies after hereditary retinoblastoma , 2011, Familial Cancer.
[23] M. Amrani,et al. Primary Carcinosarcoma of the Skin , 2010, Journal of Hand and Microsurgery.
[24] Raghu Kalluri,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[25] J. Stevenson,et al. Are primary cutaneous carcinisarcomas underdiagnosed? Five cases and a review of the literature. , 2006, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[26] P. Saadat,et al. Case report and literature review: primary cutaneous carcinosarcoma. , 2005, Annals of clinical and laboratory science.
[27] J. Carlson,et al. Cutaneous carcinosarcoma: adnexal vs. epidermal types define high‐ and low‐risk tumors. Results of a meta‐analysis , 2005, Journal of cutaneous pathology.
[28] S. Glanz,et al. β‐catenin expression in benign and malignant pilomatrix neoplasms , 2004, The British journal of dermatology.
[29] M. Stone,et al. Proliferating trichilemmal tumor with a malignant spindle cell component , 2002, Journal of cutaneous pathology.
[30] W. McCluggage,et al. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas? , 2002, Journal of clinical pathology.
[31] N. Yamazaki,et al. Malignant Eccrine Spiradenoma: A Case Report and Review of the Literature , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[32] M. Tokunaga,et al. Malignant eccrine spiradenoma with smooth muscle cell differentiation: Histological and immunohistochemical study , 1996, Pathology international.
[33] R. Ashfaq,et al. Carcinosarcoma arising in eccrine spiradenoma of the breast. Report of a case and review of the literature. , 1996, Archives of pathology & laboratory medicine.
[34] M. P. Saunders,et al. Carcinosarcoma of skin , 1995, Histopathology.
[35] W. Allsbrook,et al. Pilomatrical carcinosarcoma of the cheek with subsequent pulmonary metastases. A case report. , 1994, The American Journal of dermatopathology.
[36] M. Huerre,et al. [Carcinosarcoma arising in eccrine spiradenoma. A morphologic and immunohistochemical study]. , 1994, Annales de Pathologie.
[37] J. Val-Bernal,et al. Malignant aneuploid spindle-cell transformation in a proliferating trichilemmal tumour. , 1993, Acta Dermato-Venereologica.
[38] L. Philipson,et al. Epidural anesthesia with 0.5% bupivacaine: influence of age on sensory and motor blockade. , 1991, Anesthesia and analgesia.
[39] C. Fletcher,et al. Carcinosarcoma Arising in Eccrine Spiradenoma: A Clinicopathologic and Immunohistochemical Study of Two Cases , 1990, The American Journal of dermatopathology.
[40] G. Ricevuti,et al. The potential malignancy of eccrine spiradenoma. , 1989, The Italian journal of surgical sciences.
[41] T. Warner. Proliferating Pilar Cyst with Spindle Cell Component , 1979, Journal of cutaneous pathology.
[42] Dawson Ek. Carcino-sarcoma of the skin. , 1972 .